Related Experiment Video
Updated: Feb 14, 2026

Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs
Published on: June 12, 2018
Challenges in validating candidate therapeutic targets in cancer
Jeffrey Settleman1, Charles L Sawyers2, Tony Hunter3
1Calico Life Sciences, South San Francisco, United States.
Recent studies challenge the role of MELK (maternal embryonic leucine-rich protein kinase) as a cancer therapeutic target. This highlights issues with common research tools used in cancer drug discovery.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Maternal embryonic leucine-rich protein kinase (MELK) has been proposed as a promising therapeutic target for various human cancers.
- Over 30 publications have supported MELK's role in cancer progression and its potential as a drug target.
Purpose of the Study:
- To critically evaluate the evidence supporting MELK as a therapeutic target in human cancer.
- To investigate the reliability of research tools used in validating MELK's role in cancer.
Main Methods:
- Review of recent scientific literature and published reports.
- Analysis of experimental data and research methodologies used to study MELK.
- Assessment of the validity of commonly used research tools in cancer target validation.
Main Results:
- Three recent reports provide compelling evidence against MELK being a viable therapeutic target.
- These studies reveal significant caveats and limitations associated with the research tools previously used to support MELK's candidacy.
- The findings question the established understanding of MELK's function in cancer.
Conclusions:
- The therapeutic potential of MELK in human cancer is questionable.
- Caution is advised regarding the interpretation of results obtained using certain research tools in cancer target validation.
- Further research is needed to identify reliable therapeutic targets and validated tools for cancer treatment.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Reliability and Validity
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Therapeutic Index